Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Oncogene|January 29, 2014
A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activityP K Bajpe, A Prahallad, H Horlings, et al.
Virology|May 1, 1983
Role of adenovirus types 5 and 12 early region 1b tumor antigens in oncogenic transformationR Bernards, P I Schrier, J L Bos, et al.
Virology|April 15, 1986
Role of the adenovirus early region 1B tumor antigens in transformation and lytic infectionR Bernards, M G de Leeuw, A Houweling, et al.
The Journal of Biological Chemistry|October 18, 1996
mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defectG Hateboer, E M Hijmans, J B Nooij, et al.
The EMBO Journal|May 1, 1995
The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexesL Zhu, G Enders, J A Lees, et al.
Oncogene|October 20, 2000
p27kip1-independent cell cycle regulation by MYCK Berns, C Martins, J H Dannenberg, et al.
British Journal of Cancer|July 24, 2008
PRAME expression and clinical outcome of breast cancerM T Epping, A A M Hart, A M Glas, et al.
Genes & Development|December 1, 1998
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1R M Zwijsen, R S Buckle, E M Hijmans, et al.
The Journal of Biological Chemistry|April 3, 1999
Two E2F sites control growth-regulated and cell cycle-regulated transcription of the Htf9-a/RanBP1 gene through functionally distinct mechanismsB Di Fiore, G Guarguaglini, A Palena, et al.
Oncogene|February 16, 1999
Rapid dephosphorylation of p107 following UV irradiationP M Voorhoeve, R J Watson, P G Farlie, et al.
Pageof 9